Literature DB >> 19849697

Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.

A Zaravinos1, P Kanellou, D A Spandidos.   

Abstract

BACKGROUND: Actinic keratosis (AK) is a well-established precancerous skin lesion that has the potential to progress to squamous cell carcinoma (SCC). Basal cell carcinoma (BCC) is a locally aggressive slowly growing tumour that rarely metastasizes. A number of viruses have been proposed to play a role in the development of nonmelanoma skin cancers (NMSC), but the most plausible evidence to date suggests that cutaneous human papillomavirus (HPV) is the key instigating factor.
OBJECTIVES: To evaluate the prevalence of HPV, cytomegalovirus (CMV), herpes simplex virus (HSV) and Epstein-Barr virus (EBV) and investigate their relationship with the presence of RAS gene mutations in cutaneous lesions obtained from nonimmunosuppressed patients.
METHODS: HPV, CMV, HSV and EBV detection was performed using polymerase chain reaction (PCR) in skin biopsies (26 AK, 12 SCC and 15 BCC samples) that were collected from immunocompetent patients. The RAS mutation incidence was also investigated in all cutaneous lesions by use of PCR/restriction fragment length polymorphism and direct DNA sequencing.
RESULTS: Seventeen out of 53 (32%) skin lesions were found to be positive for HPV DNA. The highest incidences of HPV infection were five of 15 (33%) in BCC and four of 12 (33%) in SCC specimens. The HPV incidence was eight of 26 (31%) in AK and eight of 53 (15%) in normal skin tissue. Twelve out of 53 (23%) skin lesions were CMV-positive. The highest incidence of CMV infection was six of 15 (40%), observed in BCC specimens. The CMV incidence was two of 26 (8%) in AK and four of 12 (33%) in SCC. No normal skin biopsy was found to be positive for CMV. All cutaneous samples were negative for HSV and EBV DNA, as assessed by our PCR-based assays. Only three samples, one AK (4%), one BCC (6%) and one SCC (8%), were found to carry a G>T transversion at the second position of HRAS codon 12. Both HRAS mutant SCC and BCC biopsies were HPV- and CMV-positive, as well.
CONCLUSIONS: HPV DNA is detected in NMSC, AK and normal skin biopsies. Our results also indicate that CMV is involved in NMSC at higher levels than in premalignant lesions, whereas the virus was not detected in normal skin biopsies. HSV and EBV do not appear to be involved in the pathogenesis of cutaneous lesions. Moreover, we suggest that the HRAS codon 12 mutation is not a very common event in AK or NMSC. Finally, both viral infection and HRAS activation appear to represent independent factors in the aetiology of NMSC, samples of which were obtained from immunocompetent patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19849697     DOI: 10.1111/j.1365-2133.2009.09480.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy.

Authors:  Daniel N Cohen; Steven K Lawson; Aaron C Shaver; Liping Du; Harrison P Nguyen; Qin He; Douglas B Johnson; Wilfred A Lumbang; Brent R Moody; James L Prescott; Pranil K Chandra; Alan S Boyd; Jeffrey P Zwerner; Jason B Robbins; Stephen K Tyring; Peter L Rady; James D Chappell; Yu Shyr; Jeffrey R Infante; Jeffrey A Sosman
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

3.  RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.

Authors:  Patrick A Oberholzer; Damien Kee; Piotr Dziunycz; Antje Sucker; Nyam Kamsukom; Robert Jones; Christine Roden; Clinton J Chalk; Kristin Ardlie; Emanuele Palescandolo; Adriano Piris; Laura E MacConaill; Caroline Robert; Günther F L Hofbauer; Grant A McArthur; Dirk Schadendorf; Levi A Garraway
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

4.  Epstein-Barr virus induces morphological and molecular changes in thyroid neoplastic cells.

Authors:  Jacqueline Fátima Martins Almeida; José Luiz Proenca-Modena; Natássia Elena Bufalo; Karina Colombera Peres; Elisângela de Souza Teixeira; Larissa Teodoro; Raíssa Marques Beck; Ana Paula Moraes; Alfio José Tincani; Clarice Weis Arns; Laura Sterian Ward
Journal:  Endocrine       Date:  2020-03-12       Impact factor: 3.633

Review 5.  Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.

Authors:  Jennifer Wang; Bishr Aldabagh; Justin Yu; Sarah Tuttleton Arron
Journal:  J Am Acad Dermatol       Date:  2014-04       Impact factor: 11.527

Review 6.  [Actinic keratoses. Pathogenesis, clinical aspect and modern therapeutic options].

Authors:  T Strunk; R-M Szeimies
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

7.  Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report.

Authors:  C Morice; A Acher; N Soufir; M Michel; F Comoz; D Leroy; L Verneuil
Journal:  Case Rep Med       Date:  2010-12-16

8.  Spotlight on differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Dimitrios Volanis; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

9.  Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma.

Authors:  Francesca Paolini; Angelo Carbone; Maria Benevolo; Vitaliano Silipo; Francesca Rollo; Renato Covello; Paolo Piemonte; Pasquale Frascione; Rodolfo Capizzi; Caterina Catricalà; Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2011-11-14

10.  CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.